Enjoy complimentary customisation on priority with our Enterprise License!
The drugs of abuse testing market share is expected to increase by USD 1.24 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.25%.
This drugs of abuse testing market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers drug of abuse testing market segmentation by product (instruments and consumables) and Geography (North America, Europe, Asia, and Rest of World (ROW)). The drugs of abuse testing market report also offer information on several market vendors, including Abbott Laboratories, Bio Rad Laboratories Inc., CareHealth America Corp., Clinical Reference Laboratory Inc., Cordant Health Solutions, Danaher Corp., Dragerwerk AG and Co. KGaA, F. Hoffmann La Roche Ltd., Laboratory Corp. of America Holdings, Omega Laboratories Inc., Ortho-Clinical Diagnostics Inc., Precision Diagnostics, Psychemedics, Quest Diagnostics Inc., Randox Laboratories Ltd., Shimadzu Corp., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Merck KGaA, and SureHire Inc. among others.
Download the Free Report Sample to Unlock the Drugs of Abuse Testing Market Size for the Forecast Period and Other Important Statistics
The increased strategic developments is notably driving the drugs of abuse testing market growth, although factors such as high costs may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the drugs of abuse testing industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Drugs of Abuse Testing Market Driver
One of the key factors driving the global drugs of abuse testing industry growth is the increased strategic developments. The key strategies adopted include the launch of new products, product approvals, joint ventures, acquisitions, partnerships, expansion projects, collaborations, and investments. For instance, Laboratory Corp. of America Holdings (LabCorp) and the Recovery Platform jointly provide access to medication-assisted opioid treatment on a national basis in the US. The Recovery Platform has been designed to aid primary care physicians in addressing and managing the recovery of patients suffering from opioid-use disorders in a compliant and efficient manner. Similarly, Thermo Fisher Scientific provides Ortho-Clinical Diagnostics with assays which can be for monitoring drugs of abuse. Additionally, Danaher offers 6-Acetylmorphine (6-AM) and Buprenorphine (BUP) assays for drugs of abuse tests to onsite testing laboratories. Such factors are expected to support the market growth during the forecast period.
Key Drugs of Abuse Testing Market Trend
Growing adoption of information management solutions is one of the key drugs of abuse testing market trends that is expected to impact the industry positively in the forecast period. The LIMS software systems offer savings on additional costs as they eliminate the need for paper records, and a single LIMS software manages the functioning of the entire drugs of abuse testing laboratory. Vendors such as Analytical 360, CannaSafe Analytics, Cannalysis offer LIMS software programs of their own, which aid drugs of abuse testing laboratories in carrying out the analysis efficiently besides providing greater cost savings. For instance, the software program from Pharmlabs provides a comprehensive overview of the results and also offers correlation tools that are built into the results platform, which the researchers can use multiple times to generate critical analysis. Such factors will further drive market growth throughout the forecast years.
Key Drugs of Abuse Testing Market Challenge
One of the key challenges to the global drugs of abuse testing industry growth is the high costs. Key leading vendors in the market such as Merck, Shimadzu, and Thermo Fisher Scientific offer high-quality analytical products for drugs of abuse testing, but these are all very expensive, which hampers their use by laboratories. An entry-level mass spectrometer, with the most basic settings and possibly with a liquid handling system attached or in-built, costs around USD 100,000. When researchers try to add minute customizations, costs can increase exponentially as multiple parameters need to be changed by the manufacturer to make a compatible product. Thus, smaller laboratories with small budget allocations for instruments may be able to afford to purchase only basic drugs of abuse testing instruments or outsource the entire testing process. This might negatively impact the adoption of drugs of abuse testing products, thus hindering market growth during the forecast period.
This drugs of abuse testing market analysis report also provide detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global drugs of abuse testing market as a part of the global life science tools and services market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the drugs of abuse testing market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the drugs of abuse testing market encompasses successful business strategies deployed by the key vendors. The drugs of abuse testing market is fragmented and the vendors are deploying growth strategies such as the launch of new products and M and A to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The drugs of abuse testing market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the drugs of abuse testing market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
37% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for drugs of abuse testing in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).
The significant increase in the demand for drugs of abuse testing owing to the rise in cases of drug abuse will facilitate the drug of abuse testing market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
In 2020, the COVID-19 pandemic had a positive impact on the regional drugs of abuse testing market. The governments of various countries such as the US, Canada, and Mexico imposed nationwide lockdowns to curb the spread of the disease. The use of drugs increased significantly from 2020 to 2021, as users stayed at home and engaged in using illicit drugs. These factors will contribute to the increased usage of drugs of abuse testing products in the region. Thus, the regional drugs of abuse testing market is expected to witness growth during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The drugs of abuse testing market share growth by the instruments segment will be significant during the forecast period. The availability of a broad range of advanced instruments coupled with continuous innovations, which increase the overall efficiency of the drugs of abuse testing process, are the key factors that will support the growth of this segment during the forecast years.
This report provides an accurate prediction of the contribution of all the segments to the growth of the drugs of abuse testing market size and actionable market insights on post COVID-19 impact on each segment.
Drugs of Abuse Testing Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.25% |
Market growth 2022-2026 |
$ 1.24 billion |
Market structure |
Fragmented |
YoY growth (%) |
5.15 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key consumer countries |
US, Canada, Denmark, China, and India |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Abbott Laboratories, Bio Rad Laboratories Inc., CareHealth America Corp., Clinical Reference Laboratory Inc., Cordant Health Solutions, Danaher Corp., Dragerwerk AG and Co. KGaA, F. Hoffmann La Roche Ltd., Laboratory Corp. of America Holdings, Omega Laboratories Inc., Ortho-Clinical Diagnostics Inc., Precision Diagnostics, Psychemedics, Quest Diagnostics Inc., Randox Laboratories Ltd., Shimadzu Corp., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Merck KGaA, and SureHire Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.